| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 259 | 2018 |
| Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function FA Hartl, E Beck-Garcìa, NM Woessner, LJ Flachsmann, RMHV Cárdenas, ... Nature immunology 21 (8), 902-913, 2020 | 88 | 2020 |
| Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation … A Krohn, T Ahrens, A Yalcin, T Plönes, J Wehrle, S Taromi, S Wollner, ... PloS one 9 (6), e100249, 2014 | 76 | 2014 |
| CXCR4 antagonists suppress small cell lung cancer progression S Taromi, G Kayser, J Catusse, D von Elverfeldt, W Reichardt, F Braun, ... Oncotarget 7 (51), 85185, 2016 | 60 | 2016 |
| Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia N El Khawanky, A Hughes, W Yu, R Myburgh, T Matschulla, S Taromi, ... Nature communications 12 (1), 6436, 2021 | 55 | 2021 |
| The atypical kinase RIOK1 promotes tumor growth and invasive behavior F Weinberg, N Reischmann, L Fauth, S Taromi, J Mastroianni, M Köhler, ... EBioMedicine 20, 79-97, 2017 | 50 | 2017 |
| PSMA-directed CAR T cells combined with low-dose docetaxel treatment induce tumor regression in a prostate cancer xenograft model J Alzubi, V Dettmer-Monaco, J Kuehle, N Thorausch, M Seidl, S Taromi, ... Molecular Therapy-Oncolytics 18, 226-235, 2020 | 28 | 2020 |
| Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer S Taromi, F Lewens, R Arsenic, D Sedding, J Sänger, A Kunze, M Moebs, ... Oncotarget 8 (57), 97061, 2017 | 26 | 2017 |
| Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling S Reipschläger, K Kubatzky, S Taromi, M Burger, J Orth, K Aktories, ... Journal of Biological Chemistry 287 (14), 11183-11194, 2012 | 21 | 2012 |
| Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer S Taromi, E Firat, A Simonis, LM Braun, P Apostolova, M Elze, B Passlick, ... Cancer Letters 538, 215697, 2022 | 20 | 2022 |
| An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients S Taromi, G Kayser, D von Elverfeldt, W Reichardt, F Braun, WA Weber, ... Clinical & experimental metastasis 33, 651-660, 2016 | 17 | 2016 |
| Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature Medicine 24 (4), 526-526, 2018 | 8 | 2018 |
| Harnessing CD3 diversity to optimize CAR T cells RMH Velasco Cárdenas, SM Brandl, AV Meléndez, AE Schlaak, ... Nature immunology 24 (12), 2135-2149, 2023 | 7 | 2023 |
| RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer S Taromi, E Firat, A Simonis, LM Braun, P Apostolova, M Elze, B Passlick, ... Cancer Letters 520, 385-399, 2021 | 7 | 2021 |
| MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL15 and MHC class II production M Langenbach, S Giesler, S Richtsfeld, S Costa-Pereira, L Rindlisbacher, ... Molecular Cancer Research 21 (8), 849-864, 2023 | 6 | 2023 |
| Azacytidine sensitizes AML cells for effective elimination by CD123 CAR T-cells N El Khawanky, A Hughes, W Yu, S Taromi, J Clarson, AF Lopez, ... Blood 134, 3904, 2019 | 4 | 2019 |
| PO-33-Heparin suppresses progression of small cell lung cancer (SCLC) in an orthotopic mouse model S Taromi, J Catusse, DV Elverfeldt, W Reichardt, B Ledig, R Zeiser, ... Thrombosis Research 140, S188, 2016 | 3 | 2016 |
| Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861 AP Masilamani, N Huber, C Nagl, V Dettmer-Monaco, G Monaco, I Wolf, ... Frontiers in Pharmacology 14, 1211824, 2023 | 1 | 2023 |
| Author Correction: noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function FA Hartl, E Beck-Garcia, NM Woessner, LJ Flachsmann, RMHV Cardenas, ... Nature Immunology 22 (1), 100-101, 2021 | 1 | 2021 |
| ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease K Maas-Bauer, AV Stell, KL Yan, E de Vega, JM Vinnakota, S Unger, ... Nature Communications 15 (1), 446, 2024 | | 2024 |
